GlaxoSmithKline (GSKL)

1,463.75p
   
  • Change Today:
    -0.10p
  • 52 Week High: 1,676.50
  • 52 Week Low: 1,262.00
  • Currency: UK Pounds
  • Shares Issued: 4,870.09m
  • Volume: 0
  • Market Cap: £71,286m

GlaxoSmithKline Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Brands: Lucozade, Horlicks, Ribena, Paxil, Seroxat

Key Personnel

CEO: Emma Walmsley
Chief Finance Officer: Julie Brown
Independent Non-Executive Director: Harry (Hal) C. Dietz
Independent Non-Executive Director: Vishal Sikka
Independent Non-Executive Director: Elizabeth (Liz) McKee Anderson
Independent Non-Executive Director: Anne Beal
Non-Executive Chairman: Jonathan Symonds
Senior Independent Non-Executive Director: Charles Bancroft
Non-Executive Dir: Gavin Screaton, Wendy Becker , Jeannie Lee , Hal Barron

Contact Details

Address: 79 New Oxford Street, London, United Kingdom, WC1A 1DG
Phone: +44 (0)20 8047 5000
Website: http://www.gsk.com/en-gb/

Listings

Overseas Listings: LSE:GSK, NYSE:GSK
ISIN: GB0009252882

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,463.75p
Change Today -0.10p
% Change -0.70 %
52 Week High 1,676.50
52 Week Low 1,262.00
Volume 0
Shares Issued 4,870.09m
Market Cap £71,286m

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley

Top of Page